Elevated body mass index and intermediate-term clinical outcomes after acute coronary syndromes

被引:44
作者
Eisenstein, EL
McGuire, DK
Bhapkar, MV
Kristinsson, A
Hochman, JS
Kong, DF
Califf, RM
Van de Werf, F
Yancy, WS
Newby, LK
机构
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Univ Texas, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75230 USA
[4] Natl Univ Hosp Reykjavik, Reykjavik, Iceland
[5] St Lukes Roosevelt Hosp, Div Cardiol, New York, NY USA
[6] Gasthuisberg Univ, Dept Cardiol, Louvain, Belgium
关键词
obesity; body mass index; coronary artery disease; mortality; outcomes assessment; myocardial infarction;
D O I
10.1016/j.amjmed.2005.02.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Obesity is a coronary disease risk factor, but its independent effect on clinical outcomes following acute coronary syndromes has not been quantified. We evaluated the relationship between elevated body mass index (BMI) and 30-day, 90-day, and 1-year clinical outcomes postacute coronary syndromes. SUBJECTS AND METHODS: Using 15 071 patients (normal weight [BMI = 18.5-24.9 kg/m(2)], overweight [BMI = 25-29.9 kg/m(2)], obese [BMI = 30-34.9 kg/m(2)] or very obese [BMI >= 35 kg/m(2)]) randomized from 1997-1999 in the SYMPHONY (Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes) and 2nd SYMPHONY trials, we evaluated the relationships between BMI and 30-day, 90-day, and 1-year mortality and 30-day and 90-day death or myocardial infarction. RESULTS: Increasing BMI was associated with younger age, multiple comorbidities, and greater cardiac medication and procedure use; however, systolic function and coronary disease extent were similar for all BMI categories. Unadjusted Kaplan-Meier mortality estimates were higher for normal-weight patients than for all other BMI groups. After multivariable adjustment, the 30-day mortality hazard ratios (95% confidence interval [CI]) were: overweight, 0.66 (95% CI: 0.47 to 0.94); obese, 0.61 (95% CI: 0.39 to 0.97); very obese, 0.89 (95% CI: 0.48 to 1.64). Adjusted hazard ratios were similar for 90-day and 1-year mortality. There were no statistically significant differences among BMI groups in 30-day and 90-day death or myocardial infarction (unadjusted or adjusted). CONCLUSION: Overweight and obese BMI classifications were associated with better intermediate-term survival after acute coronary syndromes than normal weight and very obese, but death or myocardial infarction rates were similar. Further study is required to understand the apparent association of overweight and moderate obesity with better intermediate-term outcomes. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:981 / 990
页数:10
相关论文
共 50 条
[1]   OBESITY + CARDIAC PERFORMANCE [J].
ALEXANDER, JK .
AMERICAN JOURNAL OF CARDIOLOGY, 1964, 14 (06) :860-&
[2]   Potential impact of evidence-based medicine in acute coronary syndromes: Insights from GUSTO-IIb [J].
Alexander, KP ;
Peterson, ED ;
Granger, CB ;
Casas, AC ;
Van de Werf, F ;
Armstrong, PW ;
Guerci, A ;
Topol, EJ ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :2023-2030
[3]   Post-myocardial infarction risk stratification in elderly patients [J].
Alexander, KP ;
Galanos, AN ;
Jollis, JG ;
Stafford, JA ;
Peterson, ED .
AMERICAN HEART JOURNAL, 2001, 142 (01) :37-42
[4]   In-hospital mortality of habitual cigarette smokers after acute myocardial infarction - The 'smoker's paradox' in a countrywide study [J].
Andrikopoulos, GK ;
Richter, DJ ;
Dilaveris, PE ;
Pipilis, A ;
Zaharoulis, A ;
Gialafos, JE ;
Toutouzas, PK ;
Chimonas, ET .
EUROPEAN HEART JOURNAL, 2001, 22 (09) :776-784
[5]  
[Anonymous], 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
[6]   How should age affect management of acute myocardial infarction? A prospective cohort study [J].
Barakat, K ;
Wilkinson, P ;
Deaner, A ;
Fluck, D ;
Ranjadayalan, K ;
Timmis, A .
LANCET, 1999, 353 (9157) :955-959
[7]   EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS [J].
BARBASH, GI ;
REINER, J ;
WHITE, HD ;
WILCOX, RG ;
ARMSTRONG, PW ;
SADOWSKI, Z ;
MORRIS, D ;
AYLWARD, P ;
WOODLIEF, LH ;
TOPOL, EJ ;
CALIFF, RM ;
ROSS, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1222-1229
[8]   SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL [J].
BARBASH, GI ;
WHITE, HD ;
MODAN, M ;
DIAZ, R ;
HAMPTON, JR ;
HEIKKILA, J ;
KRISTINSSON, A ;
MOULOPOULOS, S ;
ERNESTO ;
PAOLASSO ;
VANDERWERF, T ;
PEHRSSON, K ;
SANDOE, E ;
SIMES, J ;
WILCOX, RG ;
VERSTRAETE, M ;
VONDERLIPPE, G ;
VANDEWERF, F .
CIRCULATION, 1993, 87 (01) :53-58
[9]  
Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
[10]   Obesity [J].
Bjorntorp, P .
LANCET, 1997, 350 (9075) :423-426